Theralase Technologies Inc. V.TLT

I'd Like to See a PP at $.25 with Warrants for 1 yr at $.50

[toade1313]

A PP like this would tell the investment community how undervalued the current share price is and if they want to make money they better buy now before the SP goes back to $.35-$.40.

[menoalittle]

I'd agree on the pp price, but warrants at 30 cents would be fair and offer more incentive for those buying a 25 cent placement.  But think of the message they would send the market if they cut if off at $1 million and turned everyone else wanting in away... 

[Alamir1111]

But think of the message they would send the market if they cut if off at $1 million and turned everyone else wanting in away... Smart move 3 months later come back again with a better pp

[Beano349]

The way the price moved looks like .19 or .20 is the guess.  I hope it's something a little out of the ordinary...

[Infinity]

I tend to believe that TLT has major credibility issues that needs to be addressed for any PP to succeed.  Past PP efforts clearly indicate investors are becoming warry of any proposal from the current management to raise more capital while they contiue to keep pushing time-lines further and further.  The recent spate of announcements, that have been obviously held back, for maximum

[CancerSlayer]

Yep....The company stated in their May 30 report that clinical data clarifications were identified by the FDA.  It's anybody's guess what those clarifications are.  Would also be interested in knowing if the FDA requirement to use a central lab is commonplace for this indication?.  Is it related to intrinsic data concerns or due to result variance across trial sites? Or, is

[tdon1229]

As noted previously, the FDA has been stung in recent years when granting BTD and AA to drugs, only to have them recalled later when little to no benefit was observed  Of those granted AA in the 2018-2021 period examined, fully 50% were subsequently recalled (18 of 35). FDA is attempting to clean up its now tarnished image by tightening up its oversight and reducing the number of drugs

[enriquesuave]

BTD after 63 patients is not the same as BTD after 10 patients.  After 63 patients, BTD would be like a pre approval signal from the FDA IMHO, especially if we show positive 18 and 24 months data.    

[riverrrow]

By May 30, 2023 TLT reported 39 patients had reached 450 days or 15 months.  By May 30 of this year these patients will have reached 27 months.  We're all looking forward to finding out how many have had follow ups for at least the 24 month mark and what their CR is.  Good luck to both the patients and TLT shareholders.

[Tapps21]

Hopefully management is carefully considering all options and will lead us to success.  Here's hoping. 

[plantrader]

Dr Lbiati needs to schmooze the big pharma execs... fancy dinners, sporting events, etc. LOL Some update about her efforts would be nice after a year, but that's not going to happen b/c the only update that matters is something that's material.